Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,410,000 | 5,830,000 | 5,908,000 | 7,546,000 | 10,290,000 |
| Marketable Securities | 77,000 | 75,000 | 71,000 | 69,000 | 73,000 |
| Inventories | 5,138,000 | 4,716,000 | 4,854,000 | 4,797,000 | 4,578,000 |
| Other current assets | 6,204,000 | 5,659,000 | 6,148,000 | 5,704,000 | 5,923,000 |
| TOTAL | $15,829,000 | $16,587,000 | $16,981,000 | $18,116,000 | $20,864,000 |
| Non-Current Assets | |||||
| PPE Net | 10,072,000 | 9,668,000 | 9,595,000 | 9,319,000 | 9,642,000 |
| Intangibles | 23,036,000 | 21,834,000 | 21,833,000 | 21,686,000 | 22,296,000 |
| Other Non-Current Assets | 5,542,000 | 5,357,000 | 4,711,000 | 4,997,000 | 5,194,000 |
| TOTAL | $38,650,000 | $36,859,000 | $36,139,000 | $36,002,000 | $37,132,000 |
| Total Assets | $54,479,000 | $53,446,000 | $53,120,000 | $54,118,000 | $57,996,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,285,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,362,000 | 3,120,000 | 8,514,000 | 8,155,000 | 8,592,000 |
| TOTAL | $13,919,000 | $13,417,000 | $12,750,000 | $13,796,000 | $15,786,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 15,277,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 28,653,000 | 10,541,000 | 25,436,000 | 24,317,000 | 25,054,000 |
| TOTAL | $34,019,000 | $31,151,000 | $31,039,000 | $29,770,000 | $30,802,000 |
| Total Liabilities | $47,938,000 | $44,568,000 | $43,789,000 | $43,566,000 | $46,588,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,340,000 | 1,340,000 | 1,340,000 | 1,339,000 | 1,339,000 |
| Retained earnings | -3,700,000 | -1,397,000 | -677,000 | 556,000 | 1,107,000 |
| Other shareholders' equity | 2,328,000 | 2,340,000 | 1,973,000 | 2,133,000 | 2,201,000 |
| TOTAL | $2,808,000 | $5,114,000 | $5,431,000 | $6,820,000 | $7,434,000 |
| Total Liabilities And Equity | $50,746,000 | $49,682,000 | $49,220,000 | $50,386,000 | $54,022,000 |